FDA Oversight of Clinical Trials Criticised
Reference: Demasi, M. (2022). FDA oversight of clinical trials is “grossly inadequate,” say experts. BMJ, 379, o2628. http://doi.org/10.1136/bmj.o2628 Summary: Experts are raising alarms about the US Food and Drug Administration’s (FDA) oversight of clinical trials, particularly following the expedited development of Covid-19 vaccines. A complaint by Brook Jackson, a former employee at Ventavia Research Group, […]